RxDoctor Payments Data

Logan Murray, PA

Physician Assistant · Tampa, FLNPI 1669037396

Payments from drug & device makers

$8,087in general payments, 2019–2025

Across 73 payments — averaging $110.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Blueprint Medicines Corporation$3K
  • CTI Biopharma Corp.$894
  • GSK$811
  • E.r. Squibb & Sons, L.L.C.$552
  • Bristol Myers Squibb$472
  • Servier Pharmaceuticals LLC$442
  • plus $2K from 18 others

What the payments were for

  • Consulting fees$1,80922%
  • Speaking & faculty fees$1,61320%
  • Travel & lodging$1,58220%
  • Food & beverage$2,74934%
  • Education$3354%

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,087 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$5,881
Medicare patients
33
Services billed
801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CresembaIsavuconazonium Sulfate46$271,161
ScemblixAsciminib Hydrochloride18$257,904
SprycelDasatinib12$203,978
TasignaNilotinib Hcl11$197,088
VenclextaVenetoclax39$125,615
EliquisApixaban14$8,054
Atovaquone11$8,024
Voriconazole24$5,398
Ondansetron OdtOndansetron58$1,709
Acyclovir152$1,397
Hydroxyurea32$803
Nystatin13$257
Levofloxacin39$233
Prochlorperazine Maleate17$138
Gabapentin11$134

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisScemblix, Tasigna$23$454,99229 claims
Astellas Pharma US IncCresemba$148$271,16146 claims
E.r. Squibb & Sons, L.L.C.Sprycel$552$203,97812 claims
AbbVieVenclexta$237$125,61539 claims
PfizerEliquis$48$8,05414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →